JP2000178203A5 - - Google Patents

Download PDF

Info

Publication number
JP2000178203A5
JP2000178203A5 JP1999357108A JP35710899A JP2000178203A5 JP 2000178203 A5 JP2000178203 A5 JP 2000178203A5 JP 1999357108 A JP1999357108 A JP 1999357108A JP 35710899 A JP35710899 A JP 35710899A JP 2000178203 A5 JP2000178203 A5 JP 2000178203A5
Authority
JP
Japan
Prior art keywords
transplantation
medicament
administered
days
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1999357108A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000178203A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2000178203A publication Critical patent/JP2000178203A/ja
Publication of JP2000178203A5 publication Critical patent/JP2000178203A5/ja
Pending legal-status Critical Current

Links

JP11357108A 1998-12-17 1999-12-16 ヒトにおける造血幹細胞移植後の造血及び免疫回復を刺激するためのヒト成長ホルモンの使用 Pending JP2000178203A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11266898P 1998-12-17 1998-12-17
US60/112668 1998-12-17

Publications (2)

Publication Number Publication Date
JP2000178203A JP2000178203A (ja) 2000-06-27
JP2000178203A5 true JP2000178203A5 (enExample) 2007-01-11

Family

ID=22345222

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11357108A Pending JP2000178203A (ja) 1998-12-17 1999-12-16 ヒトにおける造血幹細胞移植後の造血及び免疫回復を刺激するためのヒト成長ホルモンの使用

Country Status (9)

Country Link
US (1) US6348444B1 (enExample)
EP (1) EP1016414B1 (enExample)
JP (1) JP2000178203A (enExample)
AT (1) ATE275418T1 (enExample)
DE (1) DE69919969T2 (enExample)
DK (1) DK1016414T3 (enExample)
ES (1) ES2226326T3 (enExample)
PT (1) PT1016414E (enExample)
SI (1) SI1016414T1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1016413A1 (en) * 1998-12-30 2000-07-05 Applied Research Systems ARS Holding N.V. Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
DE60140051D1 (de) * 2000-06-07 2009-11-12 Merck Serono Sa Coinsins Menschliches wachstumshormon zur stimulierung der mobilisierung pluripotenter hämapoietischer stammzellen
BRPI0507169A (pt) * 2004-02-02 2007-06-26 Ambrx Inc polipeptìdeos do hormÈnio de crescimento humano modificados e seu usos
MX2007001589A (es) * 2004-08-09 2007-08-02 Alios Biopharma Inc Variantes de polipeptido resistentes a proteasa, hiperglicosiladas sinteticas, formulaciones orales y metodos para utilizar las mismas.
US7597884B2 (en) * 2004-08-09 2009-10-06 Alios Biopharma, Inc. Hyperglycosylated polypeptide variants and methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5199942A (en) 1991-06-07 1993-04-06 Immunex Corporation Method for improving autologous transplantation
US5202119A (en) * 1991-06-28 1993-04-13 Genentech, Inc. Method of stimulating immune response
WO1993000109A1 (en) * 1991-06-28 1993-01-07 Genentech, Inc. Method of stimulating immune response using growth hormone
JPH08511263A (ja) 1993-06-15 1996-11-26 ブリテッシュ バイオテック ファーマシューティカルズ リミテッド 造血細胞の放出と可動化
JPH07101877A (ja) * 1993-10-04 1995-04-18 Mitsui Toatsu Chem Inc 血小板減少症治療剤

Similar Documents

Publication Publication Date Title
ATE126055T1 (de) Naproxen-formulierung zur kontrollierten absorption zur einmal täglichen anwendung.
IL150127A0 (en) Flat medicinal preparation for transmucosal administration of oxycodon or a comparable active ingredient in the oral cavity, for use in pain therapy and in addiction therapy
DE60022021D1 (de) Zubereitungen enthaltend Apomorphin und Sildenafil und ihre Verwendung zur Behandlung von erektiler Dysfunktion
JP2001515712A5 (enExample)
UA81390C2 (en) Use of unrestricted somatic stem cells (ussc) for the preparation of medicinal agents
WO2000041504A3 (en) Use of tertbutylhydroquinone for lowering blood cholesterol and/or blood triblycerides
IL153288A0 (en) Use of growth hormone or a derivative thereof in the preparation of a medicament for hematopoiesis
JP2002530353A5 (enExample)
NZ332105A (en) Medicaments including human growth hormone for the treatment of type II diabetes and metabolic syndrome
JP2003501345A5 (enExample)
EP1002538A3 (en) Stem cell and lymphocyte storage
IL136415A (en) Transmucosal formulations of levosimendan
EP1016414A3 (en) Human growth hormone to stimulate hematopoiesis and immune reconstitution after hematopoietic stem cell transplantation in humans
AU2229997A (en) Pharmaceutical compositions comprising natural human alpha-interferon
JP2002534393A5 (enExample)
WO2003072019A3 (en) Sequential therapy comprising a 20(s)-camptothecin compound and a pyrimidine base analog
SE0200598D0 (sv) Pharmaceutical composition and method for treatment or prevention of vascular disease or states of tissue hypoperfusion with hypoxic and/or ischemic consequences
CN2162163Y (zh) 菊花保健枕
CN200980895Y (zh) 颈椎保健药枕
CN2274045Y (zh) 输便囊
Welch After We First Made Love
Warsh Landscape of a House at Night
SE9704451D0 (sv) New method and compositions for the treatment of autoimmune diseases
MD1469G2 (ro) Metodă de tratament al şocului combustional
CN113384418A (zh) 一种无烟灸疗舱